These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 19931462

  • 1. Carboxymethylated-kappa-casein: a convenient tool for the identification of polyphenolic inhibitors of amyloid fibril formation.
    Carver JA, Duggan PJ, Ecroyd H, Liu Y, Meyer AG, Tranberg CE.
    Bioorg Med Chem; 2010 Jan 01; 18(1):222-8. PubMed ID: 19931462
    [Abstract] [Full Text] [Related]

  • 2. (-)-epigallocatechin-3-gallate (EGCG) maintains kappa-casein in its pre-fibrillar state without redirecting its aggregation pathway.
    Hudson SA, Ecroyd H, Dehle FC, Musgrave IF, Carver JA.
    J Mol Biol; 2009 Sep 25; 392(3):689-700. PubMed ID: 19616561
    [Abstract] [Full Text] [Related]

  • 3. Kinetics of fibril formation of bovine kappa-casein indicate a conformational rearrangement as a critical step in the process.
    Leonil J, Henry G, Jouanneau D, Delage MM, Forge V, Putaux JL.
    J Mol Biol; 2008 Sep 19; 381(5):1267-80. PubMed ID: 18616951
    [Abstract] [Full Text] [Related]

  • 4. Structural requirements for the flavonoid fisetin in inhibiting fibril formation of amyloid beta protein.
    Akaishi T, Morimoto T, Shibao M, Watanabe S, Sakai-Kato K, Utsunomiya-Tate N, Abe K.
    Neurosci Lett; 2008 Oct 31; 444(3):280-5. PubMed ID: 18761054
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Methionine oxidation enhances κ-casein amyloid fibril formation.
    Koudelka T, Dehle FC, Musgrave IF, Hoffmann P, Carver JA.
    J Agric Food Chem; 2012 Apr 25; 60(16):4144-55. PubMed ID: 22443319
    [Abstract] [Full Text] [Related]

  • 9. The Effect of Milk Constituents and Crowding Agents on Amyloid Fibril Formation by κ-Casein.
    Liu J, Dehle FC, Liu Y, Bahraminejad E, Ecroyd H, Thorn DC, Carver JA.
    J Agric Food Chem; 2016 Feb 17; 64(6):1335-43. PubMed ID: 26807595
    [Abstract] [Full Text] [Related]

  • 10. Comparative study of inhibition at multiple stages of amyloid-beta self-assembly provides mechanistic insight.
    Davis TJ, Soto-Ortega DD, Kotarek JA, Gonzalez-Velasquez FJ, Sivakumar K, Wu L, Wang Q, Moss MA.
    Mol Pharmacol; 2009 Aug 17; 76(2):405-13. PubMed ID: 19483107
    [Abstract] [Full Text] [Related]

  • 11. Phenolic oxime oligomers inhibit Alzheimer's amyloid fibril formation and disaggregate fibrils in vitro.
    Dolphin GT, Renaudet O, Ouberai M, Dumy P, Garcia J, Reymond JL.
    Chembiochem; 2009 May 25; 10(8):1325-9. PubMed ID: 19415707
    [Abstract] [Full Text] [Related]

  • 12. A multimeric quinacrine conjugate as a potential inhibitor of Alzheimer's beta-amyloid fibril formation.
    Dolphin GT, Chierici S, Ouberai M, Dumy P, Garcia J.
    Chembiochem; 2008 Apr 14; 9(6):952-63. PubMed ID: 18330854
    [Abstract] [Full Text] [Related]

  • 13. Phosphatidylinositol and inositol involvement in Alzheimer amyloid-beta fibril growth and arrest.
    McLaurin J, Franklin T, Chakrabartty A, Fraser PE.
    J Mol Biol; 1998 Apr 24; 278(1):183-94. PubMed ID: 9571042
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Reconstituted micelle formation using reduced, carboxymethylated bovine kappa-casein and human beta-casein.
    Sood SM, Lekic T, Jhawar H, Farrell HM, Slattery CW.
    Protein J; 2006 Jul 24; 25(5):352-60. PubMed ID: 16947075
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of amyloid fibril formation by polyphenols: structural similarity and aromatic interactions as a common inhibition mechanism.
    Porat Y, Abramowitz A, Gazit E.
    Chem Biol Drug Des; 2006 Jan 24; 67(1):27-37. PubMed ID: 16492146
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.